Search results
Results from the WOW.Com Content Network
Worldwide, non-compliance is a major obstacle to the effective delivery of health care. 2003 estimates from the World Health Organization indicated that only about 50% of patients with chronic diseases living in developed countries follow treatment recommendations with particularly low rates of adherence to therapies for asthma, diabetes, and ...
blood glucose awareness training (to help patients with diabetic hypoglycemia) BGL: blood glucose level: BIB: brought in by BIBA: brought in by ambulance BID bid b.i.d. twice a day (from Latin bis in die) Bilat eq: bilaterally equal BiPAP: bilevel positive airway pressure: BIS: bispectral index: BiVAD: bilateral ventricular assist device (left ...
For premium support please call: 800-290-4726 more ways to reach us
Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.
Lung restriction in diabetes could result from chronic low-grade tissue inflammation, microangiopathy, and/or accumulation of advanced glycation end products. [46] In fact the presence restrictive lung defect in association with diabetes has been shown even in presence of obstructive lung diseases like asthma and COPD in diabetic patients. [47]
For Rybelsus, in a study with patients living with type 2 diabetes, patients were randomized to take 3, 7, or 14 mg daily tablets or a placebo. “The study noted a hemoglobin A1c difference from ...
On a global level, researchers found that 2.2 million new cases of type 2 diabetes and 1.2 million new cases of heart disease in 2020 were attributable to SSBs—representing about 1 in 10 new ...
Patients may experience dizziness, heart palpitations, hyperglycemia, diarrhea and muscle cramps when taking these medications. Importantly, medications that antagonize the β2 receptor (β-blockers) may significantly increase the risk of asthma exacerbations, and are generally avoided in asthmatic patients. [7]